Evolva Holding S.A.
ELVAYOTCHealthcare
$1.16
+$0.00(+0.00%)
Market Cap$518242
P/E Ratio—
52W High$1.71
52W Low$0.8983
Evolva Holding S.A. (ELVAY) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ELVAY · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.01B | $0.02B | $0.01B | $0.01B |
| Cost of Revenue | $0.00B | $0.01B | $0.02B | $0.02B | $0.01B |
| Gross Profit | $0.00B | ($0.00B) | ($0.01B) | ($0.02B) | ($0.00B) |
| Gross Margin %(computed) | — | -27.37% | -57.22% | -157.65% | -29.73% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.03B | $0.00B | $0.01B | $0.01B |
| G&A Expenses | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | ($0.00B) | $0.09B | $0.03B | $0.03B | $0.02B |
| Operating Income | $0.00B | ($0.09B) | ($0.04B) | ($0.04B) | ($0.02B) |
| Operating Margin %(computed) | — | -977.38% | -259.94% | -425.48% | -330.26% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.00B | ($0.11B) | ($0.04B) | ($0.04B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.00B) | ($0.00B) |
| Net Income | $0.00B | ($0.11B) | ($0.04B) | ($0.04B) | ($0.03B) |
| Net Margin %(computed) | — | — | -279.08% | -417.76% | -396.10% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.14 | $-19.50 | $-10.00 | $-11.72 | $-9.49 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B |
| EBITDA | $0.00B | ($0.10B) | ($0.03B) | ($0.03B) | ($0.02B) |
| EBITDA Margin %(computed) | — | — | -222.13% | -322.13% | -273.13% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CHF · B
Explore more Evolva Holding S.A. data
About Evolva Holding S.A. (ELVAY) Income Statement
Evolva Holding S.A. (ELVAY) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, ELVAY reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.00B — a net profit margin of —.
Frequently asked questions
ELVAY · 4 questionsEvolva Holding S.A. (ELVAY) reported revenue of $0.00B for 2024, down 100.0% year-over-year.
ELVAY revenueELVAY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09